GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

"Although these drugs were developed to treat other disorders, including kidney disease, heart disease and high cholesterol, ongoing studies have shown they can reduce the risk of vision loss in ...

Diabetes can affect many parts of the body, including the eyes. Routine eye exams can help identify the early stages of eye ...

This article will explain why eye screenings are crucial, how diabetic retinopathy develops, and what you can do to protect ...

Millions have diabetes without knowing it. Discover seven easily missed warning signs including unusual fatigue, vision ...

Diabetes threatens more than just blood sugar levels - discover the major body systems at risk and how to recognize warning ...

New research from the University of Dundee has shown that artificial intelligence (AI) can analyze routine eye-screening ...

Managing diabetes requires constant attention to blood sugar levels, diet, and lifestyle. However, even when people eat the ...

Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study at the University of British Columbia.